Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine: (1) the safety and pharmacokinetics of APL180
administered as a single intravenous infusion in healthy volunteers, and (2) the safety,
pharmacokinetics and pharmacodynamics of single and multiple daily intravenous infusions of
APL018 in patients with CHD